Ciliary neurotrophic factor receptor tripartite complex (CNTFR complex)

The Ciliary neurotrophic factor (CNTF) receptor tripartite complex is a multi-subunit signaling assembly located on the cell surface, primarily in the nervous system and certain metabolic tissues [1, 2]. It is composed of three distinct proteins: the ligand-specific Ciliary neurotrophic factor receptor alpha (CNTFRα), and two shared signal-transducing subunits, glycoprotein 130 (gp130) and the leukemia inhibitory factor receptor (LIFR) [1, 4]. The assembly of this complex is initiated by the binding of CNTF or its analogs to the alpha subunit, which then recruits the beta subunits to trigger intracellular signaling [1, 3]. The primary downstream pathway is the JAK/STAT3 cascade, which plays a critical role in promoting the survival and differentiation of various neuronal populations, including motor neurons and retinal cells [2, 5]. Beyond its neurotrophic functions, the complex is involved in regulating energy homeostasis and has been investigated as a target for treating obesity [6, 7]. Therapeutic strategies targeting this complex include recombinant CNTF analogs like Axokine and encapsulated cell therapies like NT-501 [2, 3]. Despite its potential, clinical applications have been hindered by challenges such as the development of neutralizing antibodies and systemic side effects like unintended weight loss [2, 7].

Other names

CNTF receptor complexCNTFR-gp130-LIFR complexCNTF tripartite receptorCiliary neurotrophic factor receptor

Ligand binding to the CNTFRα subunit induces the recruitment and heterodimerization of gp130 and LIFRβ, forming a tripartite complex that activates associated Janus kinases (JAKs) and the STAT3 signaling pathway [1, 2].